Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial - Concepedia

Concepedia

Publication | Open Access

Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

DOI Full Paper Access

12

Citations

16

References

2025

Year

E. Felip, C.I. Rojas, M. Schenker, D.M. Kowalski, Ignacio Casarini, Tibor Csőszi, Mehmet Alı Nahıt Şendur, José Diogo Martins, Antonio Calles, C.-C. Wang,

Annals of Oncology

References

	Year	Citations

Page 1